(Q50128875)

25 February 2018

title

Enhanced immunogenicity of a recombinant genital warts vaccine adjuvanted with monophosphoryl lipid A. (English)

1 reference

25 February 2018

author name string

Thompson HS

1 reference

25 February 2018

Davies ML

1 reference

25 February 2018

Watts MJ

1 reference

25 February 2018

Mann AE

1 reference

25 February 2018

Holding FP

1 reference

25 February 2018

O'Neill T

1 reference

25 February 2018

Beech JT

1 reference

25 February 2018

Thompson SJ

1 reference

25 February 2018

Leesman GD

1 reference

25 February 2018

Ulrich JT

1 reference

25 February 2018

language of work or name

English

0 references

publication date

1 December 1998

1 reference

25 February 2018

number of pages

1 reference

inferred from page(s)

published in

Vaccine

1 reference

25 February 2018

volume

1 reference

25 February 2018

issue

1 reference

25 February 2018

page(s)

1993-1999

1 reference

25 February 2018

Therapeutic Approaches to Genital Warts

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Treatment of Condyloma Acuminata by Autogenous Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Studies on vaccination against papillomaviruses: Prophylactic and therapeutic vaccination with recombinant structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Prophylactic and therapeutic vaccination against a mucosal papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Natural and synthetic trehalose diesters as immunomodulators

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Effective adjuvants for the induction of antigen-specific delayed-type hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Incorporation of cells into an ELISA system enhances antigen-driven lymphokine detection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

PROBIT: weighted probit regression analysis for estimation of biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Humoral and cellular responses induced by intradermally administered cytokine and conventional adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Induction of protective class I MHC-restricted CTL in mice by a recombinant influenza vaccine in aluminium hydroxide adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Recent advances in vaccine adjuvants: the development of MF59 emulsion and polymeric microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

Efficacy of a Recombinant Glycoprotein D Subunit Vaccine on the Development of Primary and Recurrent Ocular Infection with Herpes Simplex Virus Type 1 in Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900088-7

7 January 2021

10.1016/S0264-410X(98)00088-7

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018